These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F. Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [Abstract] [Full Text] [Related]
6. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Kojouri K, George JN. Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779 [Abstract] [Full Text] [Related]
7. Management of adult idiopathic thrombocytopenic purpura. Nakhoul IN, Kozuch P, Varma M. Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922 [Abstract] [Full Text] [Related]
8. Treatment of immune thrombocytopenic purpura in children : current concepts. Shad AT, Gonzalez CE, Sandler SG. Paediatr Drugs; 2005 Feb; 7(5):325-36. PubMed ID: 16220997 [Abstract] [Full Text] [Related]
9. New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review. Panzer S. Vox Sang; 2008 Jan; 94(1):1-5. PubMed ID: 17973895 [Abstract] [Full Text] [Related]
10. New therapies for immune thrombocytopenic purpura. Andemariam B, Bussel J. Curr Opin Hematol; 2007 Sep; 14(5):427-31. PubMed ID: 17934347 [Abstract] [Full Text] [Related]
11. Treatment of immune thrombocytopenic purpura in adults. Bussel J. Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346 [Abstract] [Full Text] [Related]
12. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Ann Intern Med; 2004 Jan 20; 140(2):112-20. PubMed ID: 14734334 [Abstract] [Full Text] [Related]
13. Current options for the treatment of idiopathic thrombocytopenic purpura. Arnold DM, Kelton JG. Semin Hematol; 2007 Oct 20; 44(4 Suppl 5):S12-23. PubMed ID: 18096468 [Abstract] [Full Text] [Related]
14. Management of patients with refractory immune thrombocytopenic purpura. George JN. J Thromb Haemost; 2006 Aug 20; 4(8):1664-72. PubMed ID: 16879206 [Abstract] [Full Text] [Related]
15. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Blood; 1996 Jul 01; 88(1):3-40. PubMed ID: 8704187 [No Abstract] [Full Text] [Related]
16. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. Lowe EJ, Buchanan GR. J Pediatr; 2002 Aug 01; 141(2):253-8. PubMed ID: 12183723 [Abstract] [Full Text] [Related]
18. [Treatment of idiopathic thrombocytopenic purpura in adults]. Godeau B, Bierling P. Presse Med; 2008 Sep 01; 37(9):1292-8. PubMed ID: 18644317 [Abstract] [Full Text] [Related]
19. ITP and international guidelines: what do we know, what do we need? Rodeghiero F, Ruggeri M. Presse Med; 2014 Apr 01; 43(4 Pt 2):e61-7. PubMed ID: 24656296 [Abstract] [Full Text] [Related]
20. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura. Scaradavou A, Bussel JB. Semin Hematol; 1998 Jan 01; 35(1 Suppl 1):52-7. PubMed ID: 9523749 [Abstract] [Full Text] [Related] Page: [Next] [New Search]